CLB Core Laboratories Inc. /DE/
Last updated: Aug 16, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 4/4 quarters. Q2 2026: $3M, Q1 2026: $2M, Q3 2025: $0M, Q2 2025: $0M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $3M vs trailing avg $1M (+245%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Missing buyback or cash flow data
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 1,518,982 shares = 3.3% of 46,095,379 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
1 open-market purchase by Bruno Lawrence
- Bruno Lawrence (Chairman and CEO) bought 5,000 shares at $10.78 on 2026-07-31
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 4 quarters but insufficient insider buying
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $0M in the last 90 days (net buying)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
No buyback-insider divergence detected